Eledon Pharmaceuticals, Inc. (ELDN) vs Exagen Inc. (XGN)
A side-by-side comparison of Eledon Pharmaceuticals, Inc. and Exagen Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ELDN
Eledon Pharmaceuticals, Inc.
$2.46HealthcareDelayed quote: Oct 6, 2026, 2:44 PM EDT
XGN
Exagen Inc.
$8.38HealthcareDelayed quote: Oct 6, 2026, 2:45 PM EDT
Total return — ELDN vs XGN
growth of $100 · dividends reinvested · last 7yELDN -81.7% (-21.6%/yr)XGN -54.5% (-10.6%/yr)XGN compounded faster over this window
ELDN XGN
ELDN vs XGN: by the numbers
- •XGN is the larger company ($202M vs $189M market cap).
- •Both run net losses; ELDN's is the smaller (0.00% vs -26.61% net margin).
Metrics side by side
Valuation
| Metric | ELDN | XGN |
|---|---|---|
| P/S ratio | N/A | 2.85 |
| P/B ratio | 5.74 | 16.58 |
Profitability
| Metric | ELDN | XGN |
|---|---|---|
| Gross margin | 0.00% | 58.64% |
| Operating margin | 0.00% | -18.58% |
| Net margin | 0.00% | -26.61% |
| ROE | -136.83% | -154.90% |
| ROIC | -74.02% | -33.88% |
Growth (annualized)
| Metric | ELDN | XGN |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 8.73% |
| Total return CAGR (5Y) | -15.17% | -8.40% |
Frequently asked
- How have ELDN and XGN total returns compared?
- Over the past 5 years, ELDN delivered -15.17% and XGN delivered -8.40% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.